Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390
https://www.fiercebiotech.com/biotech/amryt-buys-aegerion-via-bankruptcy-adding-sales-to-support-r-d
https://endpts.com/coming-out-of-chapter-11-aegerion-jumps-into-welcome-arms-of-irish-pharma-with-big-plans-fresh-60m-for-its-drugs/
https://www.fiercepharma.com/pharma/most-expensive-meds-u-s-topped-by-novartis-and-spark-gene-therapies
https://pharmaphorum.com/news/amryt-to-expand-rare-disease-portfolio-with-311m-aegerion-merger/
https://www.nasdaq.com/press-release/novelion-therapeutics-announces-subsidiary-aegerion-pharmaceuticals-to-recapitalize-through-court-20190520-00995
https://www.fiercepharma.com/pharma/top-20-most-expensive-drugs-2018-featuring-names-big-and-small